Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 253-264 of 1,909
Drug study icon
CompletedNCT01396291

Asenapine for Bipolarity

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing asenapine for Bipolarity.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.Over 18 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
CompletedNCT00764478

Asenapine for Bipolarity

This study is completed. It is testing asenapine for Bipolarity.

Location not clearly listed
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugOver 18 Years
Countries
Sponsor
Organon and Co
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2019-002213-19

A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolarity Pa...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
United Kingdom
Sponsor
University of British Columbia
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2014-003803-31

Adjunct pioglitazone IN THE TREATMENT OF Bipolarity.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Spain
Sponsor
Hospital Universitario Araba (Sede Santiago)
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2018-002263-26

Optimizing response to Li treatment through personalized evaluation of individuals with Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Denmark, Germany, Italy, ...
Sponsor
DRCI APHP
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2013-002055-15

RANDOMIZED, CONTROLLED, MULTI-CENTER, INTERNATIONAL CLINICAL STUDY ON THE MOOD-STABILIZING EFFECTS OF MEMANTINE AS AN AUGMENTING AGENT vs. LAMOTRIGINE FOR ONGOING TREATMENT IN Bipolarity type I P...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Italy
Sponsor
UNIVERSITY OF SASSARI
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.